GLOBAL HUMAN ALBUMIN MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Jan 2019 124

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.

Scope of the Report:
This report studies the Human Albumin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Albumin market by product type and applications/end industries.
Human albumin was initially used only as a volume replacement therapy; however, extensive research has shown that human albumin has numerous applications in other therapeutic areas as well. For instance, Grifols is exploring the use of the product to stabilize Alzheimer’s disease. Moreover, drugs containing human serum albumin, such as Levemir and Abraxane are used to treat diabetes and metastatic breast cancer, respectively. Furthermore, the on-going research and augmented adoption of albumin in the new therapeutic areas will boost this market’s growth during the predicted period.
The APAC region dominated the global human albumin market and accounted for most of the market share during 2017. China was the highest revenue contributor because of the increased demand for albumin. A rising patient population and easy availability of drugs will aid in the growth of this market. Moreover, the increased awareness about the therapeutic potential of immunoglobulins is expected to affect the growth of this market in APAC.
The global Human Albumin market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Albumin.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
- CSL Behring
- Grifols
- Baxalta
- Octapharma
- Kedrion

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- 5% Concentrations
- 25% Concentrations
- Others

Market Segment by Applications, can be divided into
- Therapeutics
- Drug Formulation & Vaccine
- Component of Media
- Others

Table of Contents

Related reports :

(Jun 19)

Diindolylmethane is a natural substance generated when the body breaks down indole-3-carbinol, a compound found in cruciferous vegetables su...

(Jun 19)

A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Acute medications fall into general class...

(Jun 19)

Notoginseng root extract is derived from the root of the notoginseng plant. Notoginseng is an herb primarily grown for blood-circulation rel...

(Jun 19)

ADH is a hormone stored in the posterior pituitary gland in the brain, regulating water levels in the body. ADH interacts with the kidneys t...

(Jun 19)

Scope of the Report: North America has remained a lucrative market for algae supplements, underpinned in part by the burgeoni...

(Jun 19)

Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. ...

GLOBAL HUMAN ALBUMIN MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use JUNE15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy